Dietary Phytosterols and Human Aortic Valve

NCT ID: NCT00738933

Last Updated: 2011-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled double-blind intervention study unravels influence of dietary plant sterols and stanols on the structure and the sterol composition of the human aortic valve. The study patients will include 50-60 voluntary patients from the Helsinki Univ. Central Hospital, who will undergo aortic valve surgery. The patients will be randomized into plant sterol (E), plant stanol (A) and control (C) groups. Patients in the E and A groups will be asked to consume daily 2 grams plant sterols or plant stanols, respectively, in a margarine product.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

High level of serum cholesterol is a risk factor for atherosclerotic complications, including atherosclerotic aortic valve disease. Over 50 years dietary plant sterols have been used to inhibit intestinal cholesterol absorption and to decrease its levels in serum. Daily human diet contains numerous different plant sterols, of which sitosterol and campesterol are the most abundant ones. Few epidemiologic studies suggest that sitosterol and campesterol may also be involved in formation of atherosclerotic changes in human arteries. The saturated forms of sitosterol and campesterol, i.e., the plant stanols (mainly sitostanol and campestanol) are beneficial with this respect. As part of daily diet, the plant stanols decrease absorption of both cholesterol and plant sterols, and thus, are putatively even more effective in prevention of atherosclerosis than the respective plant sterols.

Our double-blind controlled intervention study unravels influence of dietary plant sterols and stanols on the structure and the sterol composition of the human aortic valve.

50-60 patients, who will undergo aortic valve surgery, will be asked to volunteer our study. The patients will be randomized into three groups: (A) a group consuming margarine containing daily 2 grams plant stanols, (E) a group consuming margarine containing daily 2 grams of plant sterols, (C) a control group consuming margarine without any plant sterols or stanols. The dietary intervention will last for 4 to 8 weeks from the randomization to the operation.

Serum samples for analyses of serum lipids, lipoproteins and sterols will be collected at the randomization and at the operation. The atherosclerotic aortic valve will be examined with respect to its composition of cholesterol, other sterols and stanols.

The aim of our study is to elucidate the effects of dietary consumption of plant sterols and stanols on the sterol composition and structure of the atherosclerotic disease-affected aortic valve in human patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia Atherosclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

A group of patients consuming 2 grams plant stanols 4-8 weeks before the operation

Group Type ACTIVE_COMPARATOR

Dietary plant stanols

Intervention Type DIETARY_SUPPLEMENT

Daily 2 grams of plant stanols in a margarine preparation for 4-8 weeks before the operation

E

A group of patients consuming daily 2 grams plant sterols 4-8 weeks before the operation.

Group Type ACTIVE_COMPARATOR

Dietary plant sterols

Intervention Type DIETARY_SUPPLEMENT

Daily 2 grams of plant sterols in a margarine preparation for 4-8 weeks before the operation

C

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DIETARY_SUPPLEMENT

Margarine product without plant stanol or sterol esters

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary plant stanols

Daily 2 grams of plant stanols in a margarine preparation for 4-8 weeks before the operation

Intervention Type DIETARY_SUPPLEMENT

Dietary plant sterols

Daily 2 grams of plant sterols in a margarine preparation for 4-8 weeks before the operation

Intervention Type DIETARY_SUPPLEMENT

placebo

Margarine product without plant stanol or sterol esters

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Atherosclerotic aortic valve disease needing an aortic valve replacement operation

Exclusion Criteria

* None
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Eastern Finland

OTHER

Sponsor Role collaborator

University of Helsinki

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Helsinki University Central Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tatu A. Miettinen, professor

Role: PRINCIPAL_INVESTIGATOR

Dept. of Medicine, Div. of Internal Medicine, Helsinki Univ. Central Hospital, Biomedicum Helsinki

Helena Gylling, Professor

Role: PRINCIPAL_INVESTIGATOR

Department of Clinical Nutrition, University of Kuopio and Kuopion University Central Hospital, Kuopio, Finland

Markku J Nissinen, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Medicine, Div. of Gastroenterology, HUCH, Helsinki, Finland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Medicine, Div. of Internal Medicine, Helsinki Univ. Central Hospital (HUCH)

Helsinki, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Markku J. Nissinen, MD, PhD

Role: CONTACT

+358 9 4711

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Markku Nissinen, MD, PhD

Role: primary

+358 9 4711

References

Explore related publications, articles, or registry entries linked to this study.

Simonen P, Stenman UH, Gylling H. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study. Clin Sci (Lond). 2015 Sep;129(5):439-46. doi: 10.1042/CS20150193. Epub 2015 Apr 10.

Reference Type DERIVED
PMID: 25857271 (View on PubMed)

Simonen P, Lommi J, Hallikainen M, Helske-Suihko S, Werkkala K, Kupari M, Kovanen PT, Gylling H. Dietary plant stanols or sterols neither accumulate in stenotic aortic valves nor influence their structure or inflammatory status. Clin Nutr. 2015 Dec;34(6):1251-7. doi: 10.1016/j.clnu.2015.01.001. Epub 2015 Jan 7.

Reference Type DERIVED
PMID: 25614126 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

231857

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Artichoke and Bergamot Phytosome
NCT04697121 COMPLETED NA